レノックス・ガストー症候群治療の世界市場 2024-2028

概要

レノックス・ガストー症候群治療市場は、2023年から2028年にかけて6億9,980万米ドル、予測期間中のCAGRは4.29%で成長すると予測されています。

当レポートでは、レノックス・ガストー症候群治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。LGSに関する医学研究の進展、LGSに対する認識の高まり、LGSの有病率の増加などが市場を牽引しています。

本調査では、今後数年間のレノックス・ガストー症候群治療市場の成長を牽引する主要因の1つとして、LGSに対する低侵襲手術の増加を挙げています。また、LGSに対する精密医療の進歩や、LGSに対する遠隔医療や遠隔医療サービスの採用拡大も、市場の大きな需要につながると見込まれています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• レノックス・ガストー症候群治療の世界市場 2018-2022
• タイプセグメント分析 2018-2022
• エンドユーザーセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 非外科的治療：市場規模と予測 2023-2028
• 外科的治療：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院：市場規模と予測 2023-2028
• 専門クリニック：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Akron Childrens Hospital
• Cedars Sinai Health System
• Cision US Inc.
• Eisai Co. Ltd.
• Epilepsy Foundation
• GlaxoSmithKline Plc
• H Lundbeck AS
• Johnson and Johnson
• Lupin Ltd.
• Marinus Pharmaceuticals Inc.
• Sawai Group Holdings Co. Ltd.
• Supernus Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB SA
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global lennox-gastaut syndrome treatment market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on End-user - Market share 2023-2028 (%)
• Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by End-user
• Exhibits47: Data Table on Comparison by End-user
• Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by End-user ($ million)
• Exhibits61: Data Table on Market opportunity by End-user ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Akron Childrens Hospital - Overview
• Exhibits112: Akron Childrens Hospital - Product / Service
• Exhibits113: Akron Childrens Hospital - Key offerings
• Exhibits114: Cedars Sinai Health System - Overview
• Exhibits115: Cedars Sinai Health System - Product / Service
• Exhibits116: Cedars Sinai Health System - Key offerings
• Exhibits117: Cision US Inc. - Overview
• Exhibits118: Cision US Inc. - Product / Service
• Exhibits119: Cision US Inc. - Key offerings
• Exhibits120: Eisai Co. Ltd. - Overview
• Exhibits121: Eisai Co. Ltd. - Business segments
• Exhibits122: Eisai Co. Ltd. - Key offerings
• Exhibits123: Eisai Co. Ltd. - Segment focus
• Exhibits124: Epilepsy Foundation - Overview
• Exhibits125: Epilepsy Foundation - Product / Service
• Exhibits126: Epilepsy Foundation - Key offerings
• Exhibits127: GlaxoSmithKline Plc - Overview
• Exhibits128: GlaxoSmithKline Plc - Business segments
• Exhibits129: GlaxoSmithKline Plc - Key news
• Exhibits130: GlaxoSmithKline Plc - Key offerings
• Exhibits131: GlaxoSmithKline Plc - Segment focus
• Exhibits132: H Lundbeck AS - Overview
• Exhibits133: H Lundbeck AS - Product / Service
• Exhibits134: H Lundbeck AS - Key offerings
• Exhibits135: Johnson and Johnson - Overview
• Exhibits136: Johnson and Johnson - Business segments
• Exhibits137: Johnson and Johnson - Key news
• Exhibits138: Johnson and Johnson - Key offerings
• Exhibits139: Johnson and Johnson - Segment focus
• Exhibits140: Lupin Ltd. - Overview
• Exhibits141: Lupin Ltd. - Product / Service
• Exhibits142: Lupin Ltd. - Key news
• Exhibits143: Lupin Ltd. - Key offerings
• Exhibits144: Marinus Pharmaceuticals Inc. - Overview
• Exhibits145: Marinus Pharmaceuticals Inc. - Product / Service
• Exhibits146: Marinus Pharmaceuticals Inc. - Key offerings
• Exhibits147: Sawai Group Holdings Co. Ltd. - Overview
• Exhibits148: Sawai Group Holdings Co. Ltd. - Product / Service
• Exhibits149: Sawai Group Holdings Co. Ltd. - Key offerings
• Exhibits150: Supernus Pharmaceuticals Inc. - Overview
• Exhibits151: Supernus Pharmaceuticals Inc. - Product / Service
• Exhibits152: Supernus Pharmaceuticals Inc. - Key offerings
• Exhibits153: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits154: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits155: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits156: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits157: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits158: UCB SA - Overview
• Exhibits159: UCB SA - Product / Service
• Exhibits160: UCB SA - Key offerings
• Exhibits161: Viatris Inc. - Overview
• Exhibits162: Viatris Inc. - Business segments
• Exhibits163: Viatris Inc. - Key news
• Exhibits164: Viatris Inc. - Key offerings
• Exhibits165: Viatris Inc. - Segment focus
• Exhibits166: Inclusions checklist
• Exhibits167: Exclusions checklist
• Exhibits168: Currency conversion rates for US$
• Exhibits169: Research methodology
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Information sources
• Exhibits172: List of abbreviations

Abstract

The lennox-gastaut syndrome treatment market is forecasted to grow by USD 699.8 mn during 2023-2028, accelerating at a CAGR of 4.29% during the forecast period. The report on the lennox-gastaut syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in medical research on LGS, growing awareness of LGS, and increasing prevalence of LGS.

Technavio's lennox-gastaut syndrome treatment market is segmented as below:

By Type

• Non-surgical treatment
• Surgical treatment

By End-user

• Hospitals
• Specialty clinics
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rise of minimally invasive procedures for LGS as one of the prime reasons driving the lennox-gastaut syndrome treatment market growth during the next few years. Also, advancements in precision medicine for LGS and growing adoption of telehealth and telemedicine services for LGS will lead to sizable demand in the market.

The report on the lennox-gastaut syndrome treatment market covers the following areas:

• Lennox-gastaut syndrome treatment market sizing
• Lennox-gastaut syndrome treatment market forecast
• Lennox-gastaut syndrome treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lennox-gastaut syndrome treatment market vendors that include Akron Childrens Hospital, Amneal Pharmaceuticals Inc., Aquestive Therapeutics Inc., Bausch Health Companies Inc., Cedars Sinai Health System, Cision US Inc., Eisai Co. Ltd., Epilepsy Foundation, GlaxoSmithKline Plc, H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Marinus Pharmaceuticals Inc., Sawai Group Holdings Co. Ltd., Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.. Also, the lennox-gastaut syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global lennox-gastaut syndrome treatment market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global lennox-gastaut syndrome treatment market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Non-surgical treatment - Market size and forecast 2023-2028
• Exhibit 34: Chart on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
• 6.4 Surgical treatment - Market size and forecast 2023-2028
• Exhibit 38: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user
• 7.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Specialty clinics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
• Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
• Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Akron Childrens Hospital
• Exhibit 111: Akron Childrens Hospital - Overview
• Exhibit 112: Akron Childrens Hospital - Product / Service
• Exhibit 113: Akron Childrens Hospital - Key offerings
• 12.4 Cedars Sinai Health System
• Exhibit 114: Cedars Sinai Health System - Overview
• Exhibit 115: Cedars Sinai Health System - Product / Service
• Exhibit 116: Cedars Sinai Health System - Key offerings
• 12.5 Cision US Inc.
• Exhibit 117: Cision US Inc. - Overview
• Exhibit 118: Cision US Inc. - Product / Service
• Exhibit 119: Cision US Inc. - Key offerings
• 12.6 Eisai Co. Ltd.
• Exhibit 120: Eisai Co. Ltd. - Overview
• Exhibit 121: Eisai Co. Ltd. - Business segments
• Exhibit 122: Eisai Co. Ltd. - Key offerings
• Exhibit 123: Eisai Co. Ltd. - Segment focus
• 12.7 Epilepsy Foundation
• Exhibit 124: Epilepsy Foundation - Overview
• Exhibit 125: Epilepsy Foundation - Product / Service
• Exhibit 126: Epilepsy Foundation - Key offerings
• 12.8 GlaxoSmithKline Plc
• Exhibit 127: GlaxoSmithKline Plc - Overview
• Exhibit 128: GlaxoSmithKline Plc - Business segments
• Exhibit 129: GlaxoSmithKline Plc - Key news
• Exhibit 130: GlaxoSmithKline Plc - Key offerings
• Exhibit 131: GlaxoSmithKline Plc - Segment focus
• 12.9 H Lundbeck AS
• Exhibit 132: H Lundbeck AS - Overview
• Exhibit 133: H Lundbeck AS - Product / Service
• Exhibit 134: H Lundbeck AS - Key offerings
• 12.10 Johnson and Johnson
• Exhibit 135: Johnson and Johnson - Overview
• Exhibit 136: Johnson and Johnson - Business segments
• Exhibit 137: Johnson and Johnson - Key news
• Exhibit 138: Johnson and Johnson - Key offerings
• Exhibit 139: Johnson and Johnson - Segment focus
• 12.11 Lupin Ltd.
• Exhibit 140: Lupin Ltd. - Overview
• Exhibit 141: Lupin Ltd. - Product / Service
• Exhibit 142: Lupin Ltd. - Key news
• Exhibit 143: Lupin Ltd. - Key offerings
• 12.12 Marinus Pharmaceuticals Inc.
• Exhibit 144: Marinus Pharmaceuticals Inc. - Overview
• Exhibit 145: Marinus Pharmaceuticals Inc. - Product / Service
• Exhibit 146: Marinus Pharmaceuticals Inc. - Key offerings
• 12.13 Sawai Group Holdings Co. Ltd.
• Exhibit 147: Sawai Group Holdings Co. Ltd. - Overview
• Exhibit 148: Sawai Group Holdings Co. Ltd. - Product / Service
• Exhibit 149: Sawai Group Holdings Co. Ltd. - Key offerings
• 12.14 Supernus Pharmaceuticals Inc.
• Exhibit 150: Supernus Pharmaceuticals Inc. - Overview
• Exhibit 151: Supernus Pharmaceuticals Inc. - Product / Service
• Exhibit 152: Supernus Pharmaceuticals Inc. - Key offerings
• 12.15 Teva Pharmaceutical Industries Ltd.
• Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.16 UCB SA
• Exhibit 158: UCB SA - Overview
• Exhibit 159: UCB SA - Product / Service
• Exhibit 160: UCB SA - Key offerings
• 12.17 Viatris Inc.
• Exhibit 161: Viatris Inc. - Overview
• Exhibit 162: Viatris Inc. - Business segments
• Exhibit 163: Viatris Inc. - Key news
• Exhibit 164: Viatris Inc. - Key offerings
• Exhibit 165: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 168: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources
• 13.5 List of abbreviations
• Exhibit 172: List of abbreviations